[人乳头瘤病毒疫苗的不良反应]
[Adverse effects of the human papillomavirus vaccine].
作者信息
Torrecilla Rojas M Amparo, González Miguel Pedregal, Rodríguez Fermín García, Fernández Josefa Ruiz
机构信息
Distrito Condado-Campiña, Huelva, Spain.
出版信息
Aten Primaria. 2011 Jan;43(1):5-9. doi: 10.1016/j.aprim.2010.05.007. Epub 2010 Dec 15.
OBJECTIVE
To describe the most frequent adverse reactions produced by the human papillomavirus (HPV) vaccine.
DESIGN
Cross-sectional descriptive study using a telephone survey.
SETTING
A province in the Andalusian Public Health System.
PARTICIPANTS
Females vaccinated against HPV in Andalusia, selected by simple random sampling representative of the province.
MAIN MEASUREMENTS
A total of 3,135 telephone calls were made by the public service "Health Answers" using telephone operators supervised by health personnel.
RESULTS
Of the 2,880 calls that fulfilled the inclusion criteria, 1,207 people (41.9% response) took part in the survey. Of the 2,124 surveys made there was some type of adverse reaction (fever, inflammation, pain or rash) in 467 doses (22%): 6.6% was fever, 49.5% inflammation, 72.4% pain, and 6% a rash.
CONCLUSIONS
It can be said that HPV vaccine is safe, which is in agreement with that published in the summary of the product characteristics and in the literature.
目的
描述人乳头瘤病毒（HPV）疫苗产生的最常见不良反应。
设计
采用电话调查的横断面描述性研究。
地点
安达卢西亚公共卫生系统中的一个省份。
参与者
通过简单随机抽样从该省具有代表性的人群中选取的在安达卢西亚接种HPV疫苗的女性。
主要测量指标
公共服务机构“健康问答”在卫生人员监督下由电话接线员拨打了共计3135个电话。
结果
在符合纳入标准的2880个电话中，1207人（回应率41.9%）参与了调查。在进行的2124次调查中，467剂（22%）出现了某种类型的不良反应（发热、炎症、疼痛或皮疹）：发热占6.6%，炎症占49.5%，疼痛占72.4%，皮疹占6%。
结论
可以说HPV疫苗是安全的，这与产品特性摘要及文献中发表的内容一致。
Zotero 插件